Precision Medicine and Drug Resistance in Cancer Therapy

Precision Medicine and Drug Resistance in Cancer Therapy

Why does individual genetic variation affect drug response? How does drug resistance develop? What combinations of drugs and diagnostic biomarkers are ideal to address these situations? Precision medicine gives new insights into physiological and molecular mechanism of disease, which is expected to transform drug development and cancer therapy.

Projects

Mitigating Transplant Risk with Microbiome Multi-Omics Personalizing management in allogeneic hematopoietic stem cell transplantation using multi-omics biomarkers


Hijacking Transcription-Coupled DNA Repair for Cancer Therapy Overcoming DNA repair as a basis of cellular resistance to acylfulvene anticancer alkylating drugs.

Biomarkers of cancer drug-responses Quantifying molecular markers, including DNA adducts, in biological samples to elucidate impacts on drug safety and efficacy.


DNA translesion synthesis inhibition Circumventing platinum-based anti-cancer drug resistance.

JavaScript has been disabled in your browser